Back to Search
Start Over
Restoration of insulin sensitivity following treatment with imatinib mesylate (Gleevec) in non-diabetic patients with chronic myelogenic leukemia (CML).
- Source :
-
Leukemia research [Leuk Res] 2008 Apr; Vol. 32 (4), pp. 674-5. Date of Electronic Publication: 2007 Oct 24. - Publication Year :
- 2008
- Subjects :
- Adult
Benzamides
Humans
Imatinib Mesylate
Male
Middle Aged
Protein-Tyrosine Kinases antagonists & inhibitors
Treatment Outcome
Antineoplastic Agents therapeutic use
Insulin Resistance physiology
Leukemia, Myelogenous, Chronic, BCR-ABL Positive drug therapy
Piperazines therapeutic use
Pyrimidines therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 0145-2126
- Volume :
- 32
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Leukemia research
- Publication Type :
- Editorial & Opinion
- Accession number :
- 17920117
- Full Text :
- https://doi.org/10.1016/j.leukres.2007.08.014